Rebecka Michaud

Alteplase Also Shows Its Mettle for Late Strokes in HOPE Trial

February 8, 2025

You don't have permission to access "http://www.medpagetoday.com/meetingcoverage/isc/114143" on this server. Reference #18.ade5c417.1739src87711.2src58srcsrc7src https://errors.edgesuite.net/18.ade5c417.1739src87711.2src58srcsrc7src Read More

Rebecka Michaud

Alteplase Also Shows Its Mettle for Late Strokes in HOPE Trial

European Commission approves ustekinumab for paediatric Crohn’s disease

Elekta and Azra AI partner to advance cancer registry operations with AI

Organoid model integrates microglia to study inflammation in brain

Even the richest Americans face shorter lifespans than their European counterparts, study finds

‘Smart,’ ultrasound-activated immune cells may soon provide long-lasting tumor destruction

The link between renal failure and Parkinson’s disease: Researchers illuminate the underlying mechanisms

Algiax announces results from phase 2a trial for neuropathic pain treatment

Grifols collaborates with startup FcR Therapeutics to develop autoimmune therapies

A pharmacist’s guide to taking medications safely

Considerable overlap seen for children with medical complexity, autism, study shows

European Commission approves ustekinumab for paediatric Crohn’s disease

Elekta and Azra AI partner to advance cancer registry operations with AI

Organoid model integrates microglia to study inflammation in brain

Even the richest Americans face shorter lifespans than their European counterparts, study finds

‘Smart,’ ultrasound-activated immune cells may soon provide long-lasting tumor destruction

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories